AFL statement on status of AOD 9604 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The effects of 14 day infusion of saline (control), AOD9604 (250 Download Scientific Diagram The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Detection and in vitro metabolism of AOD9604 Cox 2015 Drug Testing and Analysis Wiley Online Library